There are no significant Insider Shareholders in COMPASS Pathways as of December 24, 2025.
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Life Sciences N.V. Atai | 6,905,774 | 27 Sep, 2024 | |
| George Jay Goldsmith | 6,307,970 | 25 Oct, 2024 | |
| Ekaterina Malievskaia | 6,307,970 | 25 Oct, 2024 | |
| Kabir Nath | Chief Executive Officer | 221,302 | 04 Aug, 2025 |
| Teri Loxam | Chief Financial Officer | 83,250 | 13 Mar, 2025 |
| Matthew A Owens | General Counsel & Clo | 43,340 | 05 Feb, 2024 |
| Michael Falvey | Chief Financial Officer | 22,500 | 03 Feb, 2023 |
| David Y Norton | 20,356 | 31 Mar, 2022 | |
| Annalisa Jenkins | 19,480 | 05 Aug, 2024 | |
| Guy Goodwin | Chief Medical Officer | 8,000 | 06 Apr, 2022 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 01 Aug, 2025 | Kabir Nath | Ordinary Shares | D | 6,366 | $4.34 | 221,302 | D | F |
| 11 Mar, 2025 | Kabir Nath | Ordinary Shares | A | 92,000 | $0.00 | 227,668 | D | A |
| 11 Mar, 2025 | Teri Loxam | Ordinary Shares | A | 25,000 | $0.00 | 83,250 | D | A |
| 03 Mar, 2025 | Teri Loxam | Ordinary Shares | D | 4,468 | $3.67 | 58,250 | D | F |
| 03 Mar, 2025 | Teri Loxam | - | - | 58,250 | D | |||
| 03 Feb, 2025 | Kabir Nath | Ordinary Shares | D | 15,516 | $4.31 | 135,668 | D | F |
| 24 Oct, 2024 | George Jay Goldsmith | Ordinary Shares | D | 776,565 | - | 3,155,122 | D | S |
| 24 Oct, 2024 | George Jay Goldsmith | - | - | 3,155,122 | D | |||
| 24 Oct, 2024 | Ekaterina Malievskaia | Ordinary Shares | D | 776,565 | - | 3,152,848 | D | S |
| 24 Oct, 2024 | Ekaterina Malievskaia | Ordinary Shares | D | 776,565 | - | 3,155,122 | I | S |
| 24 Oct, 2024 | George Jay Goldsmith | Ordinary Shares | D | 776,565 | - | 3,152,848 | I | S |
| 24 Oct, 2024 | George Jay Goldsmith | - | - | 3,152,848 | I | |||
| 26 Sep, 2024 | Life Sciences N.V. Atai | - | - | 6,905,774 | I | |||
| 26 Sep, 2024 | Life Sciences N.V. Atai | Ordinary Shares | D | 2,660,000 | $6.05 | 6,905,774 | I | S |
| 01 Aug, 2024 | Kabir Nath | - | - | 151,184 | D | |||
| 01 Aug, 2024 | Kabir Nath | Ordinary Shares | D | 7,064 | $6.88 | 151,184 | D | F |
| 01 Aug, 2024 | Annalisa Jenkins | Ordinary Shares | D | 161 | $6.88 | 19,480 | D | F |
| 20 May, 2024 | George Jay Goldsmith | - | - | 3,940,587 | D | |||
| 20 May, 2024 | George Jay Goldsmith | Ordinary Shares | D | 6,703 | $7.89 | 3,940,587 | D | S |
| 20 May, 2024 | Ekaterina Malievskaia | Ordinary Shares | D | 6,704 | $7.89 | 3,938,313 | D | S |